NervGen Pharma (NervGen Pharma) Other Gross PPE : $0.13 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is NervGen Pharma Other Gross PPE?

NervGen Pharma's Other Gross PPE for the quarter that ended in Mar. 2024 was $0.13 Mil.

NervGen Pharma's quarterly Other Gross PPE declined from Sep. 2023 ($0.17 Mil) to Dec. 2023 ($0.15 Mil) and declined from Dec. 2023 ($0.15 Mil) to Mar. 2024 ($0.13 Mil).

NervGen Pharma's annual Other Gross PPE increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.22 Mil) but then declined from Dec. 2022 ($0.22 Mil) to Dec. 2023 ($0.15 Mil).

NervGen Pharma Other Gross PPE Historical Data

The historical data trend for NervGen Pharma's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NervGen Pharma Other Gross PPE Chart

NervGen Pharma Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Gross PPE

Get a 7-Day Free Trial

0.22

0.15

NervGen Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Gross PPE	Get a 7-Day Free Trial															0.20	0.19	0.17	0.15	0.13

NervGen Pharma Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

NervGen Pharma (NervGen Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NervGen Pharma Corp (OTCPK:NGENF) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

9UA:Germany NGEN:Canada

Address

2955 Virtual Way, Suite 480, Vancouver, BC, CAN, V5M 4X6

Website

https://www.nervgen.com

NervGen Pharma Corp is a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases. The company is developing drugs for the treatment of spinal cord injury, multiple sclerosis, and Alzheimer's disease. It operates in a single segment, which is the research and development of pharmaceutical drugs.

NervGen Pharma (NervGen Pharma) Headlines

From GuruFocus

NervGen Pharma To Webcast At VirtualInvestorConferences.com July 11th

By PRNewswire PRNewswire • 07-09-2019